Anti-hypertensive effect and safety of long-term intake of a drink containing salmon peptide on high-normal blood pressure and mild hypertensive subjects

Japanese Pharmacology and Therapeutics

Volumn 34, Issue 10, 2006, Pages 1119-1135

  Enari, Hiroyuki ^a   Takahashi, Yoshinori ^a   Tada, Motohiko ^a   Kawarasaki, Masataka ^a   Tatsuta, Kuniaki ^b   Takeno, Ryuta ^c   Kajimoto, Osami ^d  

^a Maruha Nichiro Holdings Inc   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c Soiken Inc   (Japan)

^d Osaka University of Foreign Studies   (Japan)

Author keywords

Angiotensin I converting enzyme inhibitory activity; Blood pressure; Safety; Salmon peptide

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PEPTIDE DERIVATIVE; PLACEBO; SALMON PEPTIDE; UNCLASSIFIED DRUG;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOOD INTAKE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; PARALLEL DESIGN; SALMON; SYSTOLIC BLOOD PRESSURE;

EID: 49149087467     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Japanese source.
2. Japanese source.
3. Japanese source.
4. Japanese source.
5. Japanese source.
6. Japanese source.
7. Japanese source.
8. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 1996; 64: 767-71.
9. Japanese source.
10. Japanese source.
11. Japanese source.
12. Japanese source.
13. Japanese source.
14. Japanese source.
15. Japanese source.
16. Japanese source.
17. Japanese source.
18. Kawasaki T, Itoh K, Uezono K, Sasaki H. Estimation of 24-hour urinary sodium and potassium excretion from predicted value of 24-hour urinary creatinine excretion and fractional urine sodium/creatinine and potassium/creatinine ratio. Seventh Symposium on Salt 1993; 2: 257-62.
19. Japanese source.
20. Japanese source.
21. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003; 361: 477-85.
22. Ellerington MC, Hilled TC, Whitcroft SI, Marsh MS, Lees B, Banks LM, et al. Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcif Tissue Int 1996; 59: 6-11.
23. Goto S, Kogure K, Abe K, Kimata Y, Kitahama K, Yamashita E, et al. Efficient radical trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta 2001; 1512: 251-8.
24. Japanese source.